Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538187993&cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE" border="0" alt=""></a>

#bictegravir

Gilead Files For FDA Approval of Integrase Inhibitor–Based HIV Regimen

The single-tablet regimen includes the experimental bictegravir plus the contents of Descovy (emtricitabine/tenofovir alafenamide).

Generic image

bictegravir + tenofovir alafenamide + emtricitabine

Bictegravir Shows Promise as Part of Future Single-Tablet HIV Regimen

The investigational integrase inhibitor bictegravir appears to have a resistance profile superior to currently available drugs in its class.

Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538187994&cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE" border="0" alt=""></a>